Brain natriuretic peptide as a marker of cardiac involvement in hypertension

International Journal of Cardiology

Volumn 69, Issue 2, 1999, Pages 169-177

  Bettencourt, Paulo ^a   Ferreira, António ^a   Sousa, Tânia ^a   Ribeiro, Laura ^a   Brandão, Fernando ^a   Polónia, Jorge ^a   Cerqueira Gomes, Mário ^a   Martins, Luis ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Brain natriuretic peptide; Cardiac structure; Diastolic dysfunction; Remodelling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MALE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; TISSUE SPECIFICITY;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK FACTORS; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0033562631     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00023-6     Document Type: Article

References (39)

1. Levy D, Garrison RI, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. Sullivan JM, van der Zwaag R, El-Zeky F, Rainaanathan KB, Mirius DM. LV hypertrophy: Effects on survival. J Am Coll Cardiol 1993;22:508-13.
3. Levy D, Lanson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
4. Verdecchia P, Schillaci G, Guerrieri M, Boldrine F, Gatteschi C, Benemio G, Porcellati C. Prevalence and determinants of left ventricular diastolic filling abnormalities in an unselected hypertensive population. Eur Heart J 1990;11:679-91.
5. Phillips RA, Goldman ME, Ardeljan M, Arora R, Eison HB, Buyan Y, Krakoff LR. Determinants of abnormal left ventricular filling in early hypertension. J Am CoIl Cardiol 1989;14:979-85.
6. Genovesi-Ebert A, Marabotti C, Palombo C et al. Different determinants of left ventricular filling in normotensive subjects and essential hypertensive patients. Am J Hypertension 1989;2:117-9.
7. Ogawa Y, Nakau K, Mukoyama M, Hosoda K, Shirakaini G, Arai H, Saito Y, Suga S, Jougasaki M, Imura H. Natriuretic peptide as cardiac hormones in normotensive and spontaneously hypertensive rats: The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
8. Wilkins MR, Redondo J, Brown LA. The natriuretic-peptide family. Lancet 1997;349:1307-10.
9. Kinnunen P, Vvalteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: Effects of stretching. Endocrinology 1993;132:1961-70.
10. Magga J, Vvalteennaho O, Marttila MM, Ruskoaho H. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not on ventricular myocites. Circulation 1997;96:3053-62.
11. Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure, 5th report (JNC V). Arch Intern Med 1993;153:154-183.
12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977;55:613-8.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo B, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison of necropsy findings. Am J Cardiol 1986;57:450-8.
14. Little WC, Warner JG, Rankin KM, Kitzman DW, Cheng CP. Evaluation of left ventricular diastolic function from the pattern of left ventricular filling. Clin Cardiol 1998;21:5-9.
15. Pai RG, Buech GC. Newer Doppler measures of left ventricular diastolic function. Clin Cardiol 1996;19:277-88.
16. Kaplan NM. Hypertension: Prevalence, risks, and effect of therapy. Ann Intern Med 1983;98:705-9.
17. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
18. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350-5.
19. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-pedoe H, McMurray JJV, Dargie HJ. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
20. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator of angiotensine converting enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
21. Omland T, Aakvaag A, Bonargee VVS et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction. Circulation 1996;3:1963-9.
22. Kazuhiro Y, Burnett Jr. J, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
23. Kohno M, Horio T, Yokokawa K, Murakawa KI, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, Takeda T. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
24. Grantham JA, Borgeson DD, Stevens TL, Redfield MM, Burnett Jr. JR. Control of cardiac hypertrophy and natriuretic peptide production by endogenous angiotensin II in experimental heart failure. J Am Coll Cardiol 1997;29:483A.
25. Zachariah PK, Burnett Jr. JC, Ritter SG, Strong CG. Atrial natriuretic peptide in human essential hypertension. Mayo Clinic Proc 1987;62:782-6.
26. Montorsi P, Tonolo G, Polonia J, Hepburn D, Richards AM. Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension 1987;10:570-6.
27. Sagnella CA, Markandu ND, Shore AC, MacGregor GA. Raised circulation levels of atrial natriuretic peptides in essential hypertension. Lancet 1986;1:179-81.
28. Pontremoli R, Bezante GP, Robaudo C, Massarino F, Sofia A, Bertero G, Gnecco G, Pastorini C. Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension. Eur Heart J 1993;14:910-4.
29. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity pattern to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler cardiographic study. J Am Col Cardiol 1988;12:426-40.
30. Haug C, Metzele A, Kochs M, Hombach V, Gruner A. Plasma brain natriuretic and atrial natriuretic peptide concentration correlate with left ventricular end-diastolic pressure. Clin Cardiol 1993;16:553-7.
31. Maeda K, Tsutamoto T, Wada A, Hisamaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
32. Nishimura RA, Appleton CP, Redfield MM, Ilatrup DM, Holmes Jr. DR, Tajik J. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressure in patients with cardiomyopathy: A simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996;28:1226-33.
33. Yu CM, Sanderson YE, Shun IOL, Chan S, Yeung LYC, Hung YT, Cockrom CS, Woo KS. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Eur Heart J 1996;17:1694-702.
34. Lang CC, Prasad N, McAlpine HM, Macleod C, Lipworth BL, MacDonald TM, Struthers AD. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994;127:1635-6.
35. Kapuku GK, Seto S, Mori H et al. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. Am Heart J 1993;125:1710-6.
36. Frouad FM, Tarazi RC, Gallagar JH, MacIntyre WJ, Cook SA. Abnormal left ventricular relaxation in hypertensive patients. Clin Sci 1980;59:411S.
37. Inouye I, Massie B, Lodge D, Topic N, Silverstein D, Simpson P, Tuban J. Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension. Am J Cardiol 1984;53:120.
38. Palatino P, Visentin P, Mormino P, Canali C, Dorigatti F, Berton G, Santanastoso M et al. Structural abnormalities and not diastolic dysfunction are the earliest left ventricular changes in hypertension. Am J Hypertension 1998;11:147-54.
39. Takeinura G, Takatsu Y, Doyama K, Itoh H, Saito Y, Koshiiji M, Ando F, Fujiwara T, Nakao K, Fuliwara H. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 1998;31:254-65.